Pyridoxine Hcl



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 36.4%
Drug Use For Unknown Indication 22.7%
Convulsion 18.2%
Acquired Immunodeficiency Syndrome 13.6%
Folate Deficiency 4.5%
Surgery 4.5%
Drug Level Below Therapeutic 28.6%
Dizziness 14.3%
Medication Error 14.3%
Multi-organ Failure 14.3%
Parkinson's Disease 14.3%
Stupor 14.3%
Secondary
Drug Use For Unknown Indication 15.9%
Tuberculosis 15.4%
Hypertension 11.9%
Product Used For Unknown Indication 8.8%
Convulsion 8.5%
Renal Transplant 8.2%
Breast Cancer 6.6%
Hepatitis B 5.6%
Pulmonary Tuberculosis 3.7%
Hyperlipidaemia 3.4%
Status Epilepticus 2.4%
Epilepsy 1.6%
Accidental Exposure 1.3%
Myoclonic Epilepsy 1.3%
Prophylaxis 1.3%
Diabetes Mellitus 1.1%
Antibiotic Prophylaxis 0.8%
Eye Infection Toxoplasmal 0.8%
Peripheral Vascular Disorder 0.8%
Colon Cancer 0.5%
Spermatozoa Progressive Motility Decreased 27.7%
Spermatozoa Progressive Motility Abnormal 17.0%
Hepatotoxicity 8.5%
Drug Rash With Eosinophilia And Systemic Symptoms 6.4%
Hyperglycaemia 4.3%
Suicidal Ideation 4.3%
Vomiting 4.3%
Accidental Exposure 2.1%
Acute Tonsillitis 2.1%
Ammonia Increased 2.1%
Arthropod Sting 2.1%
Coronary Artery Stenosis 2.1%
Creutzfeldt-jakob Disease 2.1%
Dehydration 2.1%
Dermatitis Contact 2.1%
Drug Ineffective 2.1%
Drug Level Below Therapeutic 2.1%
Drug Resistance 2.1%
Haematoma 2.1%
Hypersensitivity 2.1%
Concomitant
Product Used For Unknown Indication 26.4%
Drug Use For Unknown Indication 21.9%
Prophylaxis 6.3%
Hiv Infection 6.1%
Rheumatoid Arthritis 5.1%
Pain 4.8%
Multiple Myeloma 4.5%
Tuberculosis 4.0%
Hypertension 3.0%
Depression 2.1%
Pulmonary Tuberculosis 2.0%
Premedication 1.8%
Colorectal Cancer 1.7%
Oesophageal Carcinoma 1.6%
Multiple Sclerosis 1.5%
Diabetes Mellitus 1.5%
Convulsion 1.4%
Colon Cancer 1.4%
Medical Diet 1.4%
Non-small Cell Lung Cancer 1.4%
Vomiting 13.8%
Weight Decreased 11.9%
Nephrolithiasis 5.7%
Weight Increased 5.7%
White Blood Cell Count Decreased 5.7%
Muscular Weakness 4.8%
Pruritus 4.8%
Renal Failure Acute 4.8%
Wheezing 4.8%
Sepsis 4.3%
Urticaria 4.3%
Flushing 3.8%
Pyrexia 3.8%
Respiratory Failure 3.8%
Death 3.3%
Thrombocytopenia 3.3%
Diarrhoea 2.9%
Disseminated Intravascular Coagulation 2.9%
Dyspnoea 2.9%
Epilepsy 2.9%
Interacting
Bk Virus Infection 50.0%
Smoking Cessation Therapy 50.0%
Discomfort 50.0%
Nausea 50.0%